Immune Oncology Research Institute

20/11/2025

We’re happy to share that Dr. Julia Hoveyan received the Young SIOP Network Leadership Award (YSNLA) at SIOP 2025, recognizing young professionals who are making meaningful contributions to pediatric oncology worldwide.

11/11/2025

We’re proud of Dr. Ruzanna Papyan who took part in SIOP 2025, presenting her poster:

“The Neglected Middle: Addressing AYA Cancer Care in Low- and Middle-Income Countries — Insights from the SIOP Global Health Network Working Group.”

Her work highlights an important but often overlooked population — adolescents and young adults (AYA) — and the need to strengthen cancer care systems in resource-limited settings.

Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia Pediatric Cancer and Blood Disorders Center of Armenia

09/05/2025

📢 International Summit in Immuno-Oncology!

Yerevan, Armenia | October 16–18, 2025

We're proud to be co-organizing this important summit—stay tuned for more updates! 🔬🤩

📢 We are thrilled to announce the official launch of the International Summit in Immuno-Oncology
📍📅Yerevan, Armenia | October 16–18, 2025
This summit marks the beginning of an ambitious effort to establish a world-class immuno-oncology ecosystem in Armenia. The event will bring together international experts in cancer research, clinical innovation, and translational science to foster impactful collaborations and shape the future of immunotherapy.
🌍 Stay tuned for program announcements, speaker highlights, and opportunities to participate.
🤝The summit is organized by Dr. Anna Martirosyan, Head of the Scientific Department at Santé Arménie and Translational Research Lead at the Immune Oncology Research Institute (IMMONC), and Dr. Karl Balabanian, Research Director at the Institut national de la santé et de la recherche médicale (INSERM), in collaboration with Prof. Mekinian Arsene, President of Santé Arménie; Dr. Armen Mkhitaryan, President of the Armenian Association of Clinical Pathologists and Cytologists; Prof. Gevorg Tamamyan, CEO of the Immune Oncology Research Institute; and Dr. Arsen Arakelyan, Director of the Institute of Molecular Biology /Մոլեկուլային կենսաբանության ինստիտուտ

13/03/2025

🫁📢 Թոքի քաղցկեղի բուժման նոր մեթոդը՝ ձեռնարկված Իմուն-ուռուցքաբանության Հետազոտական Ինստիտուտի կողմից 💉

Հայաստանում կփորձարկվի թոքի քաղցկեղի բուժման նոր մեթոդ. նախատեսվում է փորձարկել իմունոթերապևտիկ երկու դեղորայքի՝բալստիլիմաբի և բոտենսիլիմաբի...

17/01/2025

📢 Job Announcement

Are you looking for a job in Data Management? Stop scrolling, we are ready to hire!!

Position: Data Manager/Data Entry Operator�Location: 7 Nersisyan Street, Yerevan, Armenia (Yeolyan Hematology and Oncology Center)
Employment Type: Full-Time, On-site

About the Role:
�The Immune Oncology Research Institute is seeking a dedicated Data Manager/Data Entry Operator to join our team as part of an international research project conducted at Yeolyan Hematology and Oncology Center. The project, supported by Resonance Inc. is focused on acute lymphoblastic leukemia and plays a critical role in advancing clinical research and patient care in Armenia.

📌 Send your resume and a brief cover letter to avagyananna2010@gmail.com by January 25, 2025.

Follow the link for more details: https://immonc.org/News/Post/jobannouncement-datamanager277

19/12/2024

🫁 On December 14, 2024, the Immune Oncology Research Institute, in collaboration with the Yeolyan Hematology and Oncology Center and the Armenian Association of Hematology and Oncology, hosted the Lung Cancer Awareness conference for primary care physicians.

The event, attended by 60 healthcare professionals, focused on advancements in lung cancer screening, diagnosis, treatment, and multidisciplinary care.

Experts shared insights on innovative therapies and early detection, aiming to improve lung cancer care in Armenia. 📝🩻

17/10/2024

📰 Updates on the GI and Neuroendocrine Tumors working group❗️
📜 During its first year, the GI and Neuroendocrine Tumors Working Group of the Immune Oncology Research Institute held 26 meetings, reviewing 98 cases.

Led by Professor Philip Agop Philip, with Dr. Lilit Harutyunyan as co-chair and Mariam Sargsyan as coordinator, the group meets biweekly to discuss complex cases from Armenia’s major cancer centers: Institute of Surgery after A. Mikaelyan, Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, and the Ուռուցքաբանության ազգային կենտրոն / National Center of Oncology - Armenia.

These meetings improve treatment strategies and patient outcomes by fostering multidisciplinary collaboration and tailored care for gastrointestinal and neuroendocrine tumor cases.
📃For more information: https://immonc.org/News/Post/UpdatesonGIgroup

, , , , ,

16/10/2024

📮 Dr. Karl Balabanian’s Visit to Armenia❗️-Karl Balabanian

🔖Dr. Karl Balabanian, a distinguished immunologist and Research Director at INSERM, visited Armenia on October 1st, invited by Santé Arménie. He presented his contributions to immuno-hematology at the Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia. During his visit, Dr. Balabanian met with teams at the Immune Oncology Research Institute and the Yeolyan Center to discuss establishing Armenia’s first immune-oncology translational research lab and planning an international congress on the subject for 2025.⬇️

https://immonc.org/News/Post/256

🔖 , , , ,

24/09/2024

📰 Immune Oncology Research Institute, in collaboration with Agenus, Inc., has launched a new clinical trial, which will assess the safety and efficacy of the anti-CTLA-4 agent ( in combination with anti-PD-1 antibody in the frontline treatment of metastatic non-small cell lung cancer (NSCLC).
🔖 The study will enroll participants with a histologically confirmed diagnosis of metastatic and without targetable EGFR mutation or ALK rearrangement, while excluding those with untreated brain metastases or oligometastatic disease lacking targetable lesions.
The total estimated maximum time of study participation for each patient is approximately 49 months across 3 periods.
📜The Principal Investigator of the trial is Dr. Samvel Bardakhchyan, the study team includes Prof. Gevorg Tamamyan, Dr. Davit Zohrabyan , Dr. Liana Safaryan, and Dr Amalya Sargsyan.

🔖 ASSESSMENT OF THE SAFETY AND EFFICACY OF BALSTILIMAB IN COMBINATION WITH BOTENSILIMAB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER (IMMONC0008) - NCT06322108

Hear more about this study by the PI Dr Samvel Bardakhchyan👇

18/09/2024

🎉We are pleased to announce, that Shushan Hovsepyan is appointed as Innovation and Development Director at the Immune Oncology Research Institute

Follow the recent advancements and news in immune oncology with us✋
OncoDaily